1-154568051-C-T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_000748.3(CHRNB2):​c.7C>T​(p.Arg3Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000969 in 1,444,668 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R3G) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000097 ( 0 hom. )

Consequence

CHRNB2
NM_000748.3 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.93

Publications

0 publications found
Variant links:
Genes affected
CHRNB2 (HGNC:1962): (cholinergic receptor nicotinic beta 2 subunit) Neuronal acetylcholine receptors are homo- or heteropentameric complexes composed of homologous alpha and beta subunits. They belong to a superfamily of ligand-gated ion channels which allow the flow of sodium and potassium across the plasma membrane in response to ligands such as acetylcholine and nicotine. This gene encodes one of several beta subunits. Mutations in this gene are associated with autosomal dominant nocturnal frontal lobe epilepsy. [provided by RefSeq, Jul 2008]
CHRNB2 Gene-Disease associations (from GenCC):
  • familial sleep-related hypermotor epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nocturnal frontal lobe epilepsy 3
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.06712347).
BS2
High AC in GnomAdExome4 at 14 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRNB2NM_000748.3 linkc.7C>T p.Arg3Trp missense_variant Exon 1 of 6 ENST00000368476.4 NP_000739.1 P17787Q5SXY3
CHRNB2XR_001736952.3 linkn.274C>T non_coding_transcript_exon_variant Exon 1 of 7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRNB2ENST00000368476.4 linkc.7C>T p.Arg3Trp missense_variant Exon 1 of 6 1 NM_000748.3 ENSP00000357461.3 P17787

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000144
AC:
3
AN:
208430
AF XY:
0.0000174
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000112
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000969
AC:
14
AN:
1444668
Hom.:
0
Cov.:
31
AF XY:
0.0000125
AC XY:
9
AN XY:
717530
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33162
American (AMR)
AF:
0.00
AC:
0
AN:
43094
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25752
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38870
South Asian (SAS)
AF:
0.0000239
AC:
2
AN:
83648
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48964
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5706
European-Non Finnish (NFE)
AF:
0.00000995
AC:
11
AN:
1105826
Other (OTH)
AF:
0.0000168
AC:
1
AN:
59646
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000285
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.0000168
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Jul 01, 2014
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Arg3Trp (CGG>TGG): c.7 C>T in exon 1 of the CHRNB2 gene (NM_000748.2). The R3W variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,400 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R3W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this substitution occurs at a position that is not conserved across species, and in silico analysis predicts the R3W variant likely does not alter the protein structure/function. Additionally, this amino acid substitution does not occur within the transmembrane region of the protein, where the vast majority of pathogenic missense mutations have been identified in association with epilepsy (Steinlein et al., 2010). Therefore, based on the currently available information, it is unclear whether the R3W variant is a pathogenic mutation or a rare benign variant. The variant is found in EPILEPSY panel(s). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
13
DANN
Benign
0.96
DEOGEN2
Benign
0.35
T;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.0019
N
LIST_S2
Benign
0.53
T;T
M_CAP
Benign
0.048
D
MetaRNN
Benign
0.067
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.34
N;.
PhyloP100
-1.9
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-1.4
N;.
REVEL
Benign
0.25
Sift
Benign
0.19
T;.
Sift4G
Benign
0.19
T;.
Polyphen
0.0
B;.
Vest4
0.15
MutPred
0.39
Loss of disorder (P = 0.008);Loss of disorder (P = 0.008);
MVP
0.53
MPC
1.1
ClinPred
0.18
T
GERP RS
-8.4
PromoterAI
0.068
Neutral
Varity_R
0.053
gMVP
0.47
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs745932234; hg19: chr1-154540527; API